There’s no doubt the COVID-19 pandemic has heightened everyone’s concern about safety.
As the FDA moves into 2020, the agency is facing some hot button issues it failed to put to rest in 2019. Issues including NDMA, e-cigarettes and vaping, medical marijuana, the unregulated use of CBD oils, and asbestos in talc are all on the table.